logo

For the Inventor, By the Inventor

New York, NY, United States of America

Bio-Technology General Corporation


USPTO Granted Patents = 67


Forward Citations = 953

Loading Chart...
Loading Chart...

50 inventors (with patents filed for the assignee):

goldMedal Avigdor Levanon (26 out of 28 patents)

silverMedal Amos B Oppenheim (20 out of 23 patents)

bronzeMedal Marian Gorecki (19 out of 21 patents)

4.  Jacob R Hartman (15 out of 32 patents)

5.  Tikva Vogel (14 out of 15 patents)

6.  Moshe M Werber (12 out of 13 patents)

7.  Haim Aviv (10 out of 16 patents)

8.  Elisha P Zeelon (10 out of 10 patents)

9.  Meir Fischer (8 out of 8 patents)

10.  Rachel Guy (7 out of 9 patents)

11.  Amos Panet (7 out of 8 patents)

12.  Yaffa Beck (6 out of 6 patents)

13.  Menachem Zeevi (5 out of 5 patents)

14.  Benjamin Greenman (5 out of 5 patents)

15.  Hilla Locker-Giladi (4 out of 4 patents)


Core Competencies:
Superoxide Dismutase
Polypeptide
Gene Encoding
Factor Xa Inhibitor
Recombinant Proteins
Expression Vectors
Therapeutic Compositions
Human Growth Hormone
Cloning Methods
Fibrin Binding Domain
Oxandrolone Treatment
Hyaluronic Acid

67 patents:

1. 6670351 - Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 (2003-12-30),
2. 6610520 - Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby (2003-08-26),
3. 6576659 - Use of oxandrolone in the treatment of burns an other wounds (2003-06-10),
4. 6361772 - Human manganese superoxide dismutase DNA, its expression and method of recovering human manganese superoxide dismutase (2002-03-26),
5. 6211341 - Polypeptide having factor Xa inhibitory activity (2001-04-03),
6. 6121426 - Fibrin binding domain polypeptides and uses and methods of producing same (2000-09-19),
7. 6054291 - Expression vectors for enhanced production of polypeptides, plasmids (2000-04-25),
8. 6030611 - Therapeutic SOD compositions and uses thereof (2000-02-29),
9. 6010875 - Expressions plasmids containing the deo promoter, and bacterial hosts (2000-01-04),
10. 6008193 - Methods of using human von Willebrand factor GPIb binding domain (1999-12-28),
11. 6001604 - Refolding of proinsulins without addition of reducing agents (1999-12-14),
12. 5965383 - Fibrin binding domain polypeptides and uses and methods of producing same (1999-10-12),
13. 5948668 - Production of enzymatically active recombinant carboxypeptidase B (1999-09-07),
14. 5945304 - Expression plasmids regulated by an osmB promoter (1999-08-31),
15. 5872147 - Use of oxandrolone in the treatment of chronic obstructive pulmonary (1999-02-16),
Bio-Technology General Corporation is a biotechnology company specializing in the development, manufacturing, and commercialization of novel therapeutics and diagnostic products. With a focus on genetic engineering and molecular biology, the company aims to develop innovative solutions for various medical conditions and improve patient outcomes.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Bio-Technology General Corporation
67 Patents

#151 in New York, NY

#325 in New York

#5,451 in US

#11,018 in the World

New York, NY (US)
New York, NY, United States of America

Bio-Technology General Corporation

Forward Citations = 953

50 inventors:

goldMedal Avigdor Levanon (26 out of 28 patents)

silverMedal Amos B Oppenheim (20 out of 23 patents)

bronzeMedal Marian Gorecki (19 out of 21 patents)

4.  Jacob R Hartman (15 out of 32 patents)

5.  Tikva Vogel (14 out of 15 patents)

Please report any incorrect information to [email protected]
Loading…